Purdue Pharma, the maker of the powerful and addictive painkiller OxyContin, announced Feb. 9 that it will no longer directly promote its opioid drugs to doctors. That means that instead of commission-driven Purdue Pharma salespeople pitching doctors to write prescriptions for their drugs, information about the company’s opioids will be handled through its medical affairs department, rather than through the sales department.